Skip to main content

Audit committee

Swedish Orphan Biovitrum's Audit committee currently consists of three members: Helena Saxon (chair), Staffan Schüberg and Filippa Stenberg. All of them are independent in relation to the management of the company.

The primary purpose of the committee is to oversee Sobi's accounting and financial reporting processes and the audits of the financial statements.

As part of its responsibilities, the committee reviews annually the independent auditor’s proposed audit scope and approach, reviews in advance proposed changes in accounting principles and adjustments to financial statements that affect financial reporting, consults with management and our independent auditor regarding compliance with laws and regulations relating to financial matters, and reviews annually the compensation of our independent auditor.

The committee has implemented pre-approval procedures for audit and non-audit services performed by the external auditors and reviews matters relating to the external auditors’ independence. In addition, the committee is responsible for reviewing and approving all related party transactions.

Compensation & Benefits committee

Swedish Orphan Biovitrum’s Compensation & Benefits committee consists of four board members: Annette Clancy (chair), Helena Saxon, Christophe Bourdon and Zlatko Rihter. All of them are independent in relation to the management of the company. The company's Head of Human Resources is secretary of the committee, but is not a member.

The role of the Compensation & Benefits committee is to review Sobi's remuneration programs. As part of its responsibilities, the committee reviews the compensation arrangements for our senior management and reviews proposed stock option plans, stock purchase plans, retirement plans and any other matters relating to the compensation of our employees.

Scientific committee

Swedish Orphan Biovitrum's Scientific committee consists of two board members: Anders Ullman (chairman) and Annette Clancy. Annette Clancy is independent of the management of the company, while Anders Ullman is not independent.

The role of the Scientific committee is to advise on scientific matters. As part of its responsibilities, the committee evaluates our research strategies and reviews and reports to the board on scientific trends and emerging areas of science.

Transaction committee

Swedish Orphan Biovitrum’s Transaction committee consists of three board members: Annette Clancy (chair), Helena Saxon and Staffan Schüberg. All of them are independent of the management of the company.

The role of the Transaction committee is to advise on transactional initiatives. As part of its responsibilities, the committee evaluates our transaction strategy and reviews, recommends and reports to the board on potential transactions.